ZMIZ2 and hepatocellular carcinoma: In particular, loss and gain-of-function study, transcriptome sequencing and co-immunoprecipitation experiments were conducted to explore the significant role of ZMIZ2 in activating the Wnt/β-catenin signaling pathways to promote HCC progression.